The analysis of the distribution of CYP2C9 gene variants showed that the allele CYP2C9*2 was more present than the CYP2C9*3 both in MCS as well as in SMCS patients and in healthy subjects but not in FM/CFS group. This evidence concerns the gene CYP2C9 and myalgic encephalomeyelitis/chronic fatigue syndrome.